Novartis (NYSE:NVS)

Stock Price

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
Medicine pills

Top 5 Jefferies Big Pharma Stock Picks for Q4

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share ...
Read Full Story »
clinical trials

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward. One key analyst issued a few of its top picks ...
Read Full Story »
Prescription drugs

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

Health care has lagged the top sectors in the S&P 500 over the past year, but it is starting to catch up and some nice moves in the big pharmaceutical ...
Read Full Story »
automatic inspection machine

PDL’s Next Acquisition Target Focus Is on Hypertension

PDL BioPharma Inc. (NASDAQ: PDLI) has now shown where its next revenue stream will be coming from. The company announced on Tuesday that it has committed to an equity investment ...
Read Full Story »
investing

4 Top Jefferies Dividend-Paying Value Stocks to Buy Now

With the market running above 18,000 on the Dow and 2,100 on the S&P 500, many of our readers may be starting to wonder if it’s time to take some ...
Read Full Story »
analysis

Top Analysts Upgrades and Downgrades: AT&T, Capital One, Cisco, Novartis, Sprint, Starbucks and More

After a rather tepid start to the trading week, the futures have turned decidedly lower as Wall Street eyes a second day of selling around the world, especially in Europe. ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Capital One, Energen, Micron, Salesforce.com, United Continental, United Rentals, Viacom and More

Stocks are up for the year, but Dow and S&P futures were lower ahead of an after the payrolls and unemployment report. Now that the gains have negated the selling ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: Schwab, Dean Foods, HollyFrontier, Incyte, Newfield Exploration, Nike and More

Stocks were looking for direction on Wednesday. With the S&P 500 and Dow going positive for the year just at the end of last week, investors now have to wonder ...
Read Full Story »
Medicine pills

Jefferies Top Drug Stocks for the Rest of 2016

One key analyst firm is continuing to look at which companies in the health care space are going to return the most in 2016. For the most part, Jefferies maintained ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Stocks bounced on Thursday, but Friday's early trading indications were looking for a sharp sell-off of almost 2%, based on more oil and China weakness. This is also ahead of ...
Read Full Story »
Mattress

4 Stocks to Help You Sleep Easy as Market Falls

Markets look set for their worst two-day opening performance since 1932. If that makes you nervous for the rest of what 2016 has to offer, you’re not alone. Before panicking ...
Read Full Story »
Medicine pills

Jefferies Top Pharma Stock Picks for 2016

Although most pharmaceutical stocks might trade down in the market Monday afternoon, most investors are looking past just the day and at what these stocks can do in the future. In ...
Read Full Story »
generic drugs

FDA Grants Expanded Use of Promacta for Novartis

Novartis AG (NYSE: NVS) is one of the few companies with good news on a major market sell-off. Unfortunately, it is not big enough news to be moving the shares. ...
Read Full Story »
investor research

Is AVEO the Next Aquinox for Traders?

AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) made waves in early trading indications Monday on news of a licensing agreement with Novartis A.G. (NYSE: NVS). Both companies announced an exclusive, worldwide license ...
Read Full Story »